Literature DB >> 20609408

Emergence of chemical biology approaches to the RNAi/miRNA pathway.

Yujing Li1, Chuan He, Peng Jin.   

Abstract

RNA interference (RNAi) is a well-conserved mechanism that uses small noncoding RNAs to silence gene expression posttranscriptionally. Gene regulation by RNAi is now recognized as one of the major regulatory pathways in eukaryotic cells. Although the main components of the RNAi/miRNA pathway have been identified, the molecular mechanisms regulating the activity of the RNAi/miRNA pathway have only begun to emerge within the last couple of years. Recently, high-throughput reporter assays to monitor the activity of the RNAi/miRNA pathway have been developed and used for proof-of-concept pilot screens. Both inhibitors and activators of the RNAi/miRNA pathway have been found. Although still in its infancy, a chemical biology approach using high-throughput chemical screens should open up a new avenue for dissecting the RNAi/miRNA pathway, as well as developing novel RNAi- or miRNA-based therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20609408      PMCID: PMC2901241          DOI: 10.1016/j.chembiol.2010.05.014

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  57 in total

1.  Asymmetry in the assembly of the RNAi enzyme complex.

Authors:  Dianne S Schwarz; György Hutvágner; Tingting Du; Zuoshang Xu; Neil Aronin; Phillip D Zamore
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

2.  Functional siRNAs and miRNAs exhibit strand bias.

Authors:  Anastasia Khvorova; Angela Reynolds; Sumedha D Jayasena
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

Review 3.  Targeting RNA with small molecules.

Authors:  Yitzhak Tor
Journal:  Chembiochem       Date:  2003-10-06       Impact factor: 3.164

Review 4.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

5.  Rational siRNA design for RNA interference.

Authors:  Angela Reynolds; Devin Leake; Queta Boese; Stephen Scaringe; William S Marshall; Anastasia Khvorova
Journal:  Nat Biotechnol       Date:  2004-02-01       Impact factor: 54.908

6.  Argonaute2 is the catalytic engine of mammalian RNAi.

Authors:  Jidong Liu; Michelle A Carmell; Fabiola V Rivas; Carolyn G Marsden; J Michael Thomson; Ji-Joon Song; Scott M Hammond; Leemor Joshua-Tor; Gregory J Hannon
Journal:  Science       Date:  2004-07-29       Impact factor: 47.728

7.  Recognition of duplex RNA by helix-threading peptides.

Authors:  Barry D Gooch; Peter A Beal
Journal:  J Am Chem Soc       Date:  2004-09-01       Impact factor: 15.419

Review 8.  Obtaining and screening compound collections: a user's guide and a call to chemists.

Authors:  Paul J Hergenrother
Journal:  Curr Opin Chem Biol       Date:  2006-05-03       Impact factor: 8.822

Review 9.  The chemical and biological aspects of fluoroquinolones: reality and dreams.

Authors:  S K Bhanot; M Singh; N R Chatterjee
Journal:  Curr Pharm Des       Date:  2001-03       Impact factor: 3.116

10.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

View more
  10 in total

Review 1.  Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Nat Rev Neurosci       Date:  2012-07-20       Impact factor: 34.870

Review 2.  Gestational hypoxia and epigenetic programming of brain development disorders.

Authors:  Qingyi Ma; Fuxia Xiong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2014-09-26       Impact factor: 7.851

Review 3.  MicroRNAs in neuronal function and dysfunction.

Authors:  Heh-In Im; Paul J Kenny
Journal:  Trends Neurosci       Date:  2012-03-19       Impact factor: 13.837

Review 4.  Epigenetic mechanisms governing the process of neurodegeneration.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Mol Aspects Med       Date:  2012-07-07

5.  Diagnosing and Treating Nervous System Disorders by Targeting Novel Classes of Non-coding RNAs.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Int Drug Discov       Date:  2011 Jun-Jul

6.  Dicer functions in aquatic species.

Authors:  Yasuko Kitagishi; Naoko Okumura; Hitomi Yoshida; Chika Tateishi; Yuri Nishimura; Satoru Matsuda
Journal:  J Amino Acids       Date:  2011-06-09

Review 7.  Non-coding RNAs in chromatin disease involving neurological defects.

Authors:  Floriana Della Ragione; Miriam Gagliardi; Maurizio D'Esposito; Maria R Matarazzo
Journal:  Front Cell Neurosci       Date:  2014-02-25       Impact factor: 5.505

Review 8.  MicroRNAs as active players in the pathogenesis of multiple sclerosis.

Authors:  Chiara Fenoglio; Elisa Ridolfi; Daniela Galimberti; Elio Scarpini
Journal:  Int J Mol Sci       Date:  2012-10-15       Impact factor: 5.923

9.  Epigenetics, nervous system tumors, and cancer stem cells.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Cancers (Basel)       Date:  2011-09-13       Impact factor: 6.639

10.  Molecular Simulation Studies of 3,3'-Diindolylmethane as a Potent MicroRNA-21 Antagonist.

Authors:  Md Junaid; Raju Dash; Nazrul Islam; Jui Chowdhury; Md Jahangir Alam; Saikat Dev Nath; Mohammad Abu Sayem Shakil; Ashifa Azam; Syed Mustyen Quader; S M Zahid Hosen
Journal:  J Pharm Bioallied Sci       Date:  2017 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.